IL111579A - Use of melatonin derivatives in the preparation of pharmaceutical compositions for use in treating desynchronization disorders - Google Patents

Use of melatonin derivatives in the preparation of pharmaceutical compositions for use in treating desynchronization disorders

Info

Publication number
IL111579A
IL111579A IL11157994A IL11157994A IL111579A IL 111579 A IL111579 A IL 111579A IL 11157994 A IL11157994 A IL 11157994A IL 11157994 A IL11157994 A IL 11157994A IL 111579 A IL111579 A IL 111579A
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
melatonin derivatives
desynchronization disorders
treating
Prior art date
Application number
IL11157994A
Other languages
English (en)
Other versions
IL111579A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL111579A0 publication Critical patent/IL111579A0/xx
Publication of IL111579A publication Critical patent/IL111579A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL11157994A 1993-11-18 1994-11-10 Use of melatonin derivatives in the preparation of pharmaceutical compositions for use in treating desynchronization disorders IL111579A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/154,903 US6180657B1 (en) 1993-11-18 1993-11-18 Melatonin derivatives for use in treating desynchronization disorders

Publications (2)

Publication Number Publication Date
IL111579A0 IL111579A0 (en) 1995-01-24
IL111579A true IL111579A (en) 1999-10-28

Family

ID=22553300

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11157994A IL111579A (en) 1993-11-18 1994-11-10 Use of melatonin derivatives in the preparation of pharmaceutical compositions for use in treating desynchronization disorders

Country Status (21)

Country Link
US (1) US6180657B1 (de)
EP (1) EP0656209B1 (de)
JP (1) JPH07196504A (de)
KR (1) KR950013509A (de)
CN (1) CN1100533C (de)
AT (1) ATE239470T1 (de)
AU (1) AU7777694A (de)
CA (1) CA2135710C (de)
CZ (1) CZ288834B6 (de)
DE (1) DE69432626T2 (de)
DK (1) DK0656209T3 (de)
ES (1) ES2197904T3 (de)
HU (1) HUT72070A (de)
IL (1) IL111579A (de)
NO (1) NO307364B1 (de)
NZ (1) NZ264893A (de)
PT (1) PT656209E (de)
RU (1) RU2160101C2 (de)
SG (1) SG77569A1 (de)
UA (1) UA35588C2 (de)
ZA (1) ZA948928B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0748627A3 (de) * 1995-06-14 1997-05-21 Lilly Co Eli Melatoninagonisten zur Behandlung von gutartigen Hyperplasieformen der Prostata
CA2551117A1 (en) * 2003-12-23 2005-07-14 Abraxis Bioscience, Inc. Substituted melatonin derivatives, process for their preparation, and methods of use
AR061478A1 (es) * 2006-06-19 2008-08-27 Takeda Pharmaceutical Compuesto triciclico y composicion farmaceutica
CA2724782A1 (en) * 2008-05-19 2009-11-26 Takeda Pharmaceutical Company Limited An anti-cancer cytotoxic monoclonal antibody
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
KR20180100450A (ko) 2012-01-26 2018-09-10 반다 파마슈티칼즈, 인코퍼레이티드. 일주기 리듬 장애의 치료
MX2015007909A (es) 2012-12-18 2016-04-25 Vanda Pharmaceuticals Inc Tratamiento de trastornos del ritmo circadiano.
RU2533965C1 (ru) * 2013-07-04 2014-11-27 Государственное бюджетное учреждение здравоохранения "Самарский областной гериатрический центр" Способ нормализации циркадианных ритмов человека
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
RU2655813C1 (ru) * 2017-06-09 2018-05-29 Федеральное государственное бюджетное учреждение науки "Институт токсикологии Федерального медико-биологического агентства" Средство коррекции и профилактики состояний, вызванных нарушением суточных ритмов

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087444A (en) 1976-09-08 1978-05-02 Eli Lilly And Company Amides as ovulation inhibitors
US4600723A (en) 1983-05-18 1986-07-15 Monash University Method for minimizing disturbances in circadian rhythms of bodily performance and function
EP0126630B1 (de) * 1983-05-18 1987-09-16 Monash University Verwendung von Melatonin zur Herstellung eines Arzneimittels
US4614807A (en) 1984-10-04 1986-09-30 Eli Lilly And Company 6,7-dihalomelatonins
US4687763A (en) 1985-02-25 1987-08-18 Massachusetts Institute Of Technology Composition and method for increasing levels or release of brain serotonin
IL79264A0 (en) 1986-06-27 1986-09-30 Univ Ramot Tryptamine derivatives,pharmaceutical compositions containing them and their use in an assay for melatonin receptors
US4997845A (en) 1987-02-02 1991-03-05 Eli Lilly And Company β-alkylmelatonins as ovulation inhibitors
WO1989001472A1 (en) 1987-08-17 1989-02-23 Nelson Research & Development Co. Melatonin analogues
US5093352A (en) 1988-11-14 1992-03-03 Whitby Research, Inc. Antidepressant agents
JPH0418034A (ja) * 1990-05-11 1992-01-22 Kanegafuchi Chem Ind Co Ltd 点眼組成物
US5242941A (en) 1990-12-04 1993-09-07 State Of Oregon Methods of treating circadian rhythm disorders
IT1251544B (it) 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico
ZA928011B (en) * 1991-10-18 1993-06-23 Alza Corp Transdermal administration of melatonin.
US5196435A (en) 1991-11-21 1993-03-23 Eli Lilly And Company Melatonin derivatives and combinations with antiestrogen compounds for treating mammalian breast carcinoma
IT1254995B (it) * 1992-06-24 1995-10-11 Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani
IT1255199B (it) * 1992-07-01 1995-10-20 Franco Fraschini Farmaco sintetizzato analogo della melatonina particolarmente efficacenelle patologie che interferiscono con i ritmi circadiani
US5449683A (en) * 1992-10-01 1995-09-12 Massachussetts Institute Of Technology Methods of inducing sleep using melatonin

Also Published As

Publication number Publication date
DK0656209T3 (da) 2003-09-01
PT656209E (pt) 2003-09-30
NO307364B1 (no) 2000-03-27
CZ276494A3 (en) 1995-07-12
HU9403299D0 (en) 1995-01-30
NZ264893A (en) 1997-06-24
EP0656209A3 (de) 1995-10-11
DE69432626D1 (de) 2003-06-12
ATE239470T1 (de) 2003-05-15
CA2135710C (en) 2007-07-10
NO944340D0 (no) 1994-11-14
CZ288834B6 (cs) 2001-09-12
HUT72070A (en) 1996-03-28
RU94041028A (ru) 1996-09-20
IL111579A0 (en) 1995-01-24
CN1100533C (zh) 2003-02-05
CA2135710A1 (en) 1995-05-19
EP0656209B1 (de) 2003-05-07
SG77569A1 (en) 2001-01-16
AU7777694A (en) 1995-05-25
UA35588C2 (uk) 2001-04-16
JPH07196504A (ja) 1995-08-01
CN1107700A (zh) 1995-09-06
NO944340L (no) 1995-05-19
DE69432626T2 (de) 2004-04-08
RU2160101C2 (ru) 2000-12-10
US6180657B1 (en) 2001-01-30
ES2197904T3 (es) 2004-01-16
EP0656209A2 (de) 1995-06-07
ZA948928B (en) 1996-05-10
KR950013509A (ko) 1995-06-15

Similar Documents

Publication Publication Date Title
IL127244A (en) Substituted amines, methods of their preparation and pharmaceutical compositions containing them
HU0301601D0 (en) Bis(n-substituted)-staurosporine derivatives, their use and pharmaceutical composition containing thereof
AU2711295A (en) Combination treatment for inhibiting bone loss
AU563650B2 (en) Pharmaceutical compositions of benzothiophene derivatives
IL111579A (en) Use of melatonin derivatives in the preparation of pharmaceutical compositions for use in treating desynchronization disorders
IL111580A (en) Use of melatonin derivatives in the preparation of pharmaceutical compositions for use in treating sleep disorders
EP0328634A4 (en) Pharmaceutical compositions for the treatment of psoriasis
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
IL105475A0 (en) Pharmaceutical compositions containing 1alpha,24(r)-dihydroxy-22(e)-dehydro-vitamin d3 for treating osteoporosis
IL104409A0 (en) Pharmaceutical compositions containing pyridobenzodiazepinones for axial myopia therapy
TW218011B (de)
IL106961A0 (en) Pharmaceutical compositions for treatment of the eyes
ZA925983B (en) Pharmaceutical compositions for the treatment of skin disorders
IL116548A0 (en) Pharmaceutical compositions for treatment of the eyes

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH Patent void
NE Application for restoration - patent lapsed through non-payment of renewal fees (section 60, patents law, 5727-1967)
MM9K Patent not in force due to non-payment of renewal fees